Maike Becker
Maike Becker has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Erik Schulze Zur Wiesche
Dr. August Wolff GmbH & Co. KG Arzneimittel Bielefeld Germany
2 shared publications - Jörn Michael Völker
Faculty of Chemistry, Biochemistry III (BCIII), University of Bielefeld
2 shared publications - Alexandra Lendvai
Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, University of Debrecen, Debrecen, Hungary
1 shared publication Alfredo Rossi
Dermatology Clinic, Department of Clinical Internal. Anesthesiologic and Cardiovascular Sciences Sapienza University of Rome Rome Italy
1 shared publication- Arpad Lanyi
Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
1 shared publication - Attila Bacsi
Department of Immunology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary
1 shared publication
Latest Publications
- Open Access
- 18 August 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (8) , e70390
A Novel Approach Against Male Pattern Hair Loss With Topical Dimethylglycine Sodium Salt (DMG‐Na) and Caffeine: Efficacy of a 24‐Week, Double‐Blind, Randomized, Placebo‐Controlled Trial
Background: Male pattern hair loss is the most common form of hair loss in men, occurring in specific patterns. Contributing factors include hormonal changes, stress, malnutrition, and insufficient blood microcirculation.Objective: Topical applied dimethylglycine sodium salt (DMG‐Na) has been identified to increase skin microcirculation by activating endothelial nitric oxide synthase and inducing nitric oxide production. Given the importance of sufficient microcirculation on hair growth, the goal of this study was to evaluate the effectiveness of topically applied DMG‐Na in combination with caffeine against male pattern hair loss.Methods: A 24‐week, double‐blind, randomized, placebo‐controlled trial was conducted on 154 men with male pattern hair loss, treated with a DMG‐Na and caffeine‐containing shampoo or the corresponding placebo. The primary efficacy parameter was the change in the number of hairs pulled via hair pull test from baseline to 6 months of daily product application. Clinical efficacy was further evaluated via phototrichogram analysis on a subgroup of 30 subjects.Results: The decreased number of hairs pulled during the hair pull test after 6 months of active shampoo application was significantly higher compared to the placebo (−2.8 ± 1.6 vs. 0.6 ± 2.2; p < 0.001), with no reported adverse events. Phototrichogram results showed an increase in the number of hairs, hair density, and percentage of anagen hairs after 6 months of active shampoo usage (p < 0.001).Conclusion: The clinical efficacy of this novel DMG‐Na and caffeine‐containing shampoo demonstrates significant potential against male pattern hair loss, offering promising results without any undesirable side effects.
- 18 August 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (8) , e70390
Open AccessA Novel Approach Against Male Pattern Hair Loss With Topical Dimethylglycine Sodium Salt (DMG‐Na) and Caffeine: Efficacy of a 24‐Week, Double‐Blind, Randomized, Placebo‐Controlled Trial
Background: Male pattern hair loss is the most common form of hair loss in men, occurring in specific patterns. Contributing factors include hormonal changes, stress, malnutrition, and insufficient blood microcirculation.Objective: Topical applied dimethylglycine sodium salt (DMG‐Na) has been identified to increase skin microcirculation by activating endothelial nitric oxide synthase and inducing nitric oxide production. Given the importance of sufficient microcirculation on hair growth, the goal of this study was to evaluate the effectiveness of topically applied DMG‐Na in combination with caffeine against male pattern hair loss.Methods: A 24‐week, double‐blind, randomized, placebo‐controlled trial was conducted on 154 men with male pattern hair loss, treated with a DMG‐Na and caffeine‐containing shampoo or the corresponding placebo. The primary efficacy parameter was the change in the number of hairs pulled via hair pull test from baseline to 6 months of daily product application. Clinical efficacy was further evaluated via phototrichogram analysis on a subgroup of 30 subjects.Results: The decreased number of hairs pulled during the hair pull test after 6 months of active shampoo application was significantly higher compared to the placebo (−2.8 ± 1.6 vs. 0.6 ± 2.2; p < 0.001), with no reported adverse events. Phototrichogram results showed an increase in the number of hairs, hair density, and percentage of anagen hairs after 6 months of active shampoo usage (p < 0.001).Conclusion: The clinical efficacy of this novel DMG‐Na and caffeine‐containing shampoo demonstrates significant potential against male pattern hair loss, offering promising results without any undesirable side effects.
- Open Access
- 24 May 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (12) , 2823-2827.e6
Topically Applied N,N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release
- 24 May 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (12) , 2823-2827.e6
Open AccessTopically Applied N,N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release